Kenneth Rivlin

Kenneth Rivlin

Auto-generated profile, based on publicly available information

Kenneth Rivlin

New York City Health + Hospitals

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2026 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
CDCandice Deler
Candice Deler
SMSalma Muhyedeen
Salma Muhyedeen
TDToni Denicola
Toni Denicola
CACandace Alphonso
Candace Alphonso
UPUrvi Patel
Urvi Patel
KRKenneth Rivlin
Kenneth Rivlin
Objectives: Hydroxyurea (HU) is an evidence-based, disease-modifying therapy that reduces complications for individuals with sickle cell disease (SCD). Despite its benefits, HU uptake remains suboptimal, particularly in historically marginalized communities facing barriers such as healthcare mistrust, misinformation, and structural inequities. In 2020, NYC Health + Hospitals (H + H) launched a citywide initiative, funded by the US Office of Minority Health, to improve HU use by partnering with community-based organizations (CBOs) and community health workers (CHWs) to address these barriers. Methods: The initiative was evaluated through an independent, mixed-methods study conducted by the New York State Department of Health. This system-wide intervention reached over 300 providers, with 99 actively participating in the incentive program, and impacted approximately 400 pediatric patients annually, with outcomes assessed in a matched cohort of 730 Medicaid-enrolled patients. Our CBO’s intervention involved culturally grounded health education, peer support, and practical assistance with non-clinical needs. Evaluation methods included qualitative interviews with clinicians, CHWs, and program leaders, supplemented by quantitative analyses of healthcare utilization and pharmacy data from pre- (2019) and post-intervention (2022-2023) periods. Results: The CBO–hospital partnership was essential to the initiative’s success. The CBO provided trusted community infrastructure, within which CHWs delivered frontline education, navigation, and social support, addressed social determinants of health and strengthened trust between families and clinical teams. Statistically significant improvements were observed: HU fills increased from 57% to 79%, adherence improved from 33% to 40%, and patients seen by participating providers were significantly less likely to have emergency department visits after adjustment. Qualitative data confirmed that the CBO-anchored CHW model was a critical driver of these outcomes. Conclusion: Integrating trusted community organizations into clinical care models can overcome entrenched barriers, improve HU adherence, and advance health equity in SCD care.

17 January 2025 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
SGStephanie Howe Guarino
Stephanie Howe Guarino
MMMohan Madisetti
Mohan Madisetti
PDPayal C Desai
Payal C Desai
AJAkshat Jain
Akshat Jain
KRKenneth Rivlin
Kenneth Rivlin
JKJulie Kanter
Julie Kanter
Objective: The objective of this pilot project was to create a standardized Transition Note in the electronic health record (EHR) to facilitate clinician communication during the transition process from pediatric to adult care for youth with sickle cell disease (SCD). Methods: Using a modified Delphi process, consensus was reached among 78 member centers from the National Alliance of Sickle Cell Centers (NASCC) on the essential health data elements for a standardized EHR Transition Note. Templates were created in 2 different EHR systems and piloted at 2 SCD centers. Perceived clinician acceptability, appropriateness, and feasibility were assessed using the AIM-IAM-FAM measures and quality with the GQS (ranges 1.0-5.0). Results: Consensus was reached for the inclusion of 126 discrete elements in the development of a standardized SCD EHR Transition Note including SCD complications, treatments, medical and social history, and health maintenance results. Use of templates among clinicians (N = 4) proved to be acceptable (mean 4.5), appropriate (mean 4.6), and feasible (mean 4.4). The overall mean clinician GQS score was 5.0. Conclusion: The Transition Note templates developed under this pilot are currently undergoing larger scale testing and evaluation, but preliminary data indicates the templates are usable and useful. User guides will be created for the integration of these templates into the EHR systems at other SCD centers. Interoperability between different EHR systems and dynamic data pulls from the medical record to automate the population of data fields are viewed as areas for future work to both reduce the burden of manual data entry and to facilitate adoption.

17 January 2025 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
KRKenneth Rivlin
Kenneth Rivlin
SVStamatia Vorri
Stamatia Vorri
MAMelanie Aviles
Melanie Aviles
KEKristina Emeghebo
Kristina Emeghebo
SUSana Usmani
Sana Usmani
AEAntonia P Eyssallenne
Antonia P Eyssallenne
Lay Summary: As we celebrate 50 years of newborn screening (NBS) for sickle cell disease (SCD), we must confront its hidden failure: the neglect of sickle cell trait (SCT). Identified in thousands of newborns annually, SCT status is often lost in a system with no clear owner for communicating its lifelong implications to families. This gap leads to missed opportunities for reproductive planning, widens health disparities, and undermines public trust. We present public health precedents that provide a pathway to integrating SCT counseling into routine care and urge stakeholders to move beyond identification to action and fulfill the original promise of NBS.

24 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
AZAnna Zhilkova
Anna Zhilkova
KRKenneth Rivlin
Kenneth Rivlin
JJJenai Jackson
Jenai Jackson
JGJeffrey Glassberg
Jeffrey Glassberg
BMBrittany McCrary
Brittany McCrary
AEAntonia Eyssallenne
Antonia Eyssallenne
Importance: Sickle cell disease (SCD) affects approximately 100,000 people in the United States, causes life-threatening complications, and shortens life expectancy by decades. Adults with SCD routinely encounter undertreated pain, provider bias, and structural barriers in hospital settings. Objective: To describe patterns of leave against medical advice (LAMA) among adults hospitalized for SCD. Design, Setting, and Participants: Retrospective analysis of inpatient discharge records among adults ages 18 and older in New York City hospitals, 2022-2023, hospitalized for SCD or any reason. Main Outcomes and Measures: The primary outcome was hospital-level LAMA, measured by crude rates and rates adjusting for patient characteristics using Bayesian hierarchical models. The secondary outcome was 30-day all-cause readmissions, stratified by LAMA status. Results: LAMA discharges comprised 14% of SCD hospitalizations and 4% of all-cause hospitalizations. Adjusted hospital-level SCD LAMA ranged from under 5% to 30% (IQR: 10–20%) and was higher than all-cause LAMA in most facilities. Crude SCD LAMA rates exceeded 30% in several hospitals, including those with more than 100 SCD hospitalizations during the study period. Patients with 10 or more SCD hospitalizations accounted for 40% of total SCD volume. Sensitivity analyses accounting for this concentration showed attenuated but persistent variation in SCD LAMA. Over 50% of SCD LAMA discharges were followed by a 30-day readmission compared to 38% of non-LAMA discharges. LAMA was associated with higher adjusted odds of readmissions in both SCD and all-cause hospitalizations. Conclusions: Our findings challenge the assumption that patients are solely responsible for early departures. Leaving against medical advice should be monitored as a signal of unmet care needs in SCD.